
CGP-049090
CAS No. 35082-49-6
CGP-049090 ( CGP049090 | Cercosporin )
产品货号. M14198 CAS No. 35082-49-6
一种小分子,可特异性抑制结肠癌细胞系中 β-catenin/LEF1 转录复合物的相互作用。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2827 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称CGP-049090
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述一种小分子,可特异性抑制结肠癌细胞系中 β-catenin/LEF1 转录复合物的相互作用。
-
产品描述A small-molecule that specifically inhibits the interaction of β-catenin/LEF1 transcriptional complex in colon carcinoma cell lines; efficiently kills CLL cells with LC50 of <1 uM, without significantly toxcity for normal B cells; is well tolerated and exhibits tumor inhibition in in vivo studies.
-
体外实验Cercosporin (0.8-8.0 μM; 30 s, 60 s, 90 s, 120 s) photodynamic therapy (PDT) effect is stronger in T98G cells than in U87 or MCF7 cells, the LD50 value for the T98G cells (0.14 J cm2) is much less than the LD50 value for MCF-7 and U87 cell lines (0.26 and 0.24 J cm2, respectively).Cercosporin (0-3 μΜ; 24 hours) interplays with copper results in a synergistic cytotoxicity in MCF7 and T98G cells, that is, S(CuSO4 + Cerco) ? S(CuSO4) x S(Cerco), barely has an additive effect in U87 cells. Cell Viability Assay Cell Line:Human GBM cell lines, T98G and U87; Breast carcinoma cell line, MCF-7 Concentration:0 μM, 1 μM, 2 μM, 3 μMIncubation Time:24 hours Result:Exhibited a synergistic cytotoxicity with copper only in the most respiratory cell lines (MCF-7 and T98G).
-
体内实验——
-
同义词CGP049090 | Cercosporin
-
通路Wnt/Notch/Hedgehog
-
靶点Beta-catenin
-
受体Beta-catenin
-
研究领域——
-
适应症——
化学信息
-
CAS Number35082-49-6
-
分子量534.517
-
分子式C29H26O10
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : ≥ 10 mg/mL (18.71 mM)
-
SMILESCC(CC1=C2C3=C(C(=C(C4=C3C5=C6C2=C(C(=O)C=C6OCOC5=CC4=O)C(=C1OC)O)O)OC)CC(C)O)O
-
化学全称6,12-dihydroxy-8,9-bis((R)-2-hydroxypropyl)-7,10-dimethoxyperyleno[1,12-def][1,3]dioxepine-5,11-dione
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Gandhirajan RK, et al. Neoplasia. 2010 Apr;12(4):326-35.
2. Minke KS, et al. Eur J Haematol. 2009 Mar;82(3):165-75.
3. Wei W, et al. Int J Cancer. 2010 May 15;126(10):2426-36.
产品手册




关联产品
-
iCRT-3
iCRT-3 是一种选择性、细胞渗透性 β-连环蛋白响应性转录 (CRT) 抑制剂,IC50 为 8.2 nM。
-
CCT-031374 hydrobrom...
一种新型小分子 Wnt 信号传导抑制剂,可抑制 TCF 依赖性转录,在 7dF3 报告基因测定中 IC50 为 6.1 uM。
-
β-catenin-IN-37
β-catenin-IN-37 是一种新型有效、选择性小分子抑制剂,可抑制 β-catenin/Tcf4 蛋白-蛋白相互作用,Ki 为 17 uM。